Ziprasidone is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Viona Pharmaceuticals Inc. The primary component is Ziprasidone Hydrochloride.
| Product ID | 72578-021_195e476b-10b8-4a68-8c7e-8edbf29aed21 |
| NDC | 72578-021 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ziprasidone |
| Generic Name | Ziprasidone |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-09-15 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA208988 |
| Labeler Name | Viona Pharmaceuticals Inc |
| Substance Name | ZIPRASIDONE HYDROCHLORIDE |
| Active Ingredient Strength | 40 mg/1 |
| Pharm Classes | Atypical Antipsychotic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-09-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59762-1006 | Ziprasidone | ziprasidone |
| 59762-2001 | Ziprasidone | ziprasidone hydrochloride |
| 59762-2002 | Ziprasidone | ziprasidone hydrochloride |
| 59762-2003 | Ziprasidone | ziprasidone hydrochloride |
| 59762-2004 | Ziprasidone | ziprasidone hydrochloride |
| 68382-237 | Ziprasidone | Ziprasidone |
| 68382-238 | Ziprasidone | Ziprasidone |
| 68382-239 | Ziprasidone | Ziprasidone |
| 68382-240 | Ziprasidone | Ziprasidone |
| 69189-2003 | Ziprasidone | Ziprasidone |
| 70771-1182 | Ziprasidone | Ziprasidone |
| 70771-1181 | Ziprasidone | Ziprasidone |
| 70771-1180 | Ziprasidone | Ziprasidone |
| 70771-1179 | Ziprasidone | Ziprasidone |
| 72578-022 | Ziprasidone | Ziprasidone |
| 72578-021 | Ziprasidone | Ziprasidone |
| 72578-020 | Ziprasidone | Ziprasidone |
| 72578-023 | Ziprasidone | Ziprasidone |
| 0049-0352 | Geodon | ziprasidone |
| 0049-0356 | Geodon | ziprasidone |
| 0049-0358 | Geodon | ziprasidone |